Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$17,500.00
FAN1 as a Genetic Modifier in Rett Syndrome
EF 2021-22
Résumé
Rett syndrome (RTT) is a severe neurodevelopmental disorder which primarily effects females and is characterized by loss of motor, coordination and communication abilities. Over 95% of individuals with RTT have a mutation in the MECP2 gene, resulting in the gene not functioning properly, leading to disease. However, variable severity is observed in patients with RTT. One possible explanation for this observation are modifier genes. Such modifiers are genes that do not directly cause disease, but can alter the severity and age of onset of genetic diseases. In addition to explaining the variable severity seen in RTT, modifier genes may aid in the discovery of new treatment options. This is of particular importance in RTT, as current treatments focus on symptomatic treatment and have limited effectiveness. For instance, one recent study in mice found that a mutation in the FAN1 gene improved the health and life span of mice with classic RTT Mecp2 mutations. The FAN1 gene is involved in DNA repair and has previously been shown to influence the age of onset of the neurodegenerative disease, Huntington disease. It is therefore the goal of this project to determine if the FAN1 modifier effect for RTT detected in mice, also has beneficial consequences in human RTT cells that resemble those found in the brain. Specifically, if there is a beneficial effect of FAN1 loss at the molecular level in patient-derived cells. To accomplish this, genomic and molecular methods will be used.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466832
Name
Slike Alana
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
FAN1 as a Genetic Modifier in Rett Syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Dna Repair; Fan1; Genomics; Induced Pluripotent Stem Cells; Mecp2; Modifier Genes; Neurodevelopmental Disorders; Neuroscience; Rett Syndrome
Abstract
Rett syndrome (RTT) is a severe neurodevelopmental disorder which primarily effects females and is characterized by loss of motor, coordination and communication abilities. Over 95% of individuals with RTT have a mutation in the MECP2 gene, resulting in the gene not functioning properly, leading to disease. However, variable severity is observed in patients with RTT. One possible explanation for this observation are modifier genes. Such modifiers are genes that do not directly cause disease, but can alter the severity and age of onset of genetic diseases. In addition to explaining the variable severity seen in RTT, modifier genes may aid in the discovery of new treatment options. This is of particular importance in RTT, as current treatments focus on symptomatic treatment and have limited effectiveness. For instance, one recent study in mice found that a mutation in the FAN1 gene improved the health and life span of mice with classic RTT Mecp2 mutations. The FAN1 gene is involved in DNA repair and has previously been shown to influence the age of onset of the neurodegenerative disease, Huntington disease. It is therefore the goal of this project to determine if the FAN1 modifier effect for RTT detected in mice, also has beneficial consequences in human RTT cells that resemble those found in the brain. Specifically, if there is a beneficial effect of FAN1 loss at the molecular level in patient-derived cells. To accomplish this, genomic and molecular methods will be used.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Slike, Alana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~